Oluwole S F, Jin M X, Chowdhury N C, Engelstad K, Ohajekwe O A, James T
Department of Surgery, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA.
Cell Immunol. 1995 Apr 15;162(1):33-41. doi: 10.1006/cimm.1995.1048.
Intrathymic (IT) inoculation of soluble alloantigens (Ag) obtained from 3 M KCl extracts of resting T-cells induces donor-specific tolerance to cardiac allografts and islet allografts. This study examined the cellular basis of induction of transplantation tolerance by IT injection of soluble Ag. Our results show that while IT inoculation of 2 mg soluble donor Ag on Day -7 relative to Lewis islet transplantation induced specific unresponsiveness to islet allografts (> 200 days) in naive diabetic recipients, IT inoculation of 2 mg soluble Ag on the same day as islet transplantation did not prolong islet allograft survival in the same Lewis-to-WF rat combination. To define the role of donor APCs in intrathymic tolerance, we showed that IT injection of an admixture of 1 x 10(4) donor DC and 2 mg soluble Ag caused acute islet graft rejection. In contrast, addition of 1 x 10(4) recipient-type DC to the IT inoculum did not prevent long-term graft survival. This finding suggests that while the presence of donor APCs in the inoculum does not appear necessary for IT-alloantigen to induce peripheral tolerance, presentation of the soluble Ag in the thymus is dependent on host APCs. This conclusion is supported by our in vitro MLR experiments which showed that in vivo WF-Ag-primed Lewis T-cells proliferated specifically to WF-soluble Ag and that the response was enhanced 14-fold by the addition of responder-type DC. Addition of anti-Lewis MHC class II mAb specifically blocked the alloresponse, thus suggesting that in vivo Ag-primed T-cells are capable of recognizing and proliferating in response to allopeptides presented by responder APCs. We also showed that adoptive transfer of syngeneic naive T-cells into unresponsive recipients failed to break tolerance to long-term surviving islet allografts. This finding suggests that tolerance in this model is not due to a lack of T help. On the other hand, the adoptive transfer of spleen cells, but not sera, from the unresponsive WF recipients bearing long-term (> 120 days) functioning Lewis islets resulted in prolonged survival of donor-type but not third-party islet allografts in secondary syngeneic hosts. Our data suggest that the tolerogenic effect of IT inoculation of soluble Ag is dependent on the indirect pathway of Ag presentation and clonal deletion of alloreactive T-cells in the thymus, while suppressor/regulatory mechanism may be involved in the maintenance of peripheral tolerance.
将从静息T细胞的3M KCl提取物中获得的可溶性同种异体抗原(Ag)进行胸腺内(IT)接种,可诱导对心脏同种异体移植和胰岛同种异体移植的供体特异性耐受。本研究检测了通过IT注射可溶性Ag诱导移植耐受的细胞基础。我们的结果显示,相对于Lewis胰岛移植,在第-7天进行2mg可溶性供体Ag的IT接种可诱导未致敏糖尿病受体对胰岛同种异体移植产生特异性无反应性(>200天),而在胰岛移植当天进行2mg可溶性Ag的IT接种,在相同的Lewis到WF大鼠组合中并未延长胰岛同种异体移植的存活时间。为了确定供体抗原呈递细胞(APC)在胸腺内耐受中的作用,我们发现IT注射1×10⁴个供体树突状细胞(DC)和2mg可溶性Ag的混合物会导致急性胰岛移植排斥。相反,在IT接种物中添加1×10⁴个受体型DC并不能阻止长期移植存活。这一发现表明,虽然接种物中供体APC的存在对于IT同种异体抗原诱导外周耐受似乎并非必要,但胸腺中可溶性Ag的呈递依赖于宿主APC。我们的体外混合淋巴细胞反应(MLR)实验支持了这一结论,该实验显示体内经WF-Ag致敏的Lewis T细胞对WF可溶性Ag特异性增殖,并且通过添加反应型DC,反应增强了14倍。添加抗Lewis MHC II类单克隆抗体可特异性阻断同种异体反应,因此表明体内Ag致敏的T细胞能够识别并对反应型APC呈递的同种异体肽增殖。我们还表明,将同基因未致敏T细胞过继转移到无反应受体中未能打破对长期存活的胰岛同种异体移植的耐受。这一发现表明该模型中的耐受并非由于缺乏T辅助。另一方面,从长期(>120天)功能正常的Lewis胰岛的无反应WF受体中过继转移脾细胞而非血清,可导致供体型而非第三方胰岛同种异体移植在二次同基因宿主中的存活时间延长。我们的数据表明,IT接种可溶性Ag的致耐受作用依赖于Ag呈递的间接途径以及胸腺中同种异体反应性T细胞的克隆清除,而抑制/调节机制可能参与外周耐受的维持。